Overview
Mario Dorostkar practices practicing medicine in Munich, Germany.
Mr. Dorostkar is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Midline Lethal Granuloma, Ependymoma, Glioma, and Gliomatosis Cerebri.
He is actively involved in clinical research, co-authoring 61 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mario M. Dorostkar
Is Mario M. Dorostkar a top-rated expert for Midline Lethal Granuloma?
MediFind is an objective health platform that identifies experts based on real-world data. Mario M. Dorostkar is classified as an Advanced expert for Midline Lethal Granuloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mario M. Dorostkar participate in research or clinical trials?
Yes. Mario M. Dorostkar has published 61 articles and abstracts on conditions like Midline Lethal Granuloma. You can view a list of Mario M. Dorostkar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EpendymomaMr. Dorostkar isAdvanced. Learn about Ependymoma.
- GliomaMr. Dorostkar isAdvanced. Learn about Glioma.
- Gliomatosis CerebriMr. Dorostkar isAdvanced. Learn about Gliomatosis Cerebri.
- Midline Lethal GranulomaMr. Dorostkar isAdvanced. Learn about Midline Lethal Granuloma.
- Experienced
- Alzheimer's DiseaseMr. Dorostkar isExperienced. Learn about Alzheimer's Disease.
- AstrocytomaMr. Dorostkar isExperienced. Learn about Astrocytoma.
- Brain TumorMr. Dorostkar isExperienced. Learn about Brain Tumor.
- Corticobasal DegenerationMr. Dorostkar isExperienced. Learn about Corticobasal Degeneration.
- DementiaMr. Dorostkar isExperienced. Learn about Dementia.
- GlioblastomaMr. Dorostkar isExperienced. Learn about Glioblastoma.
- MedulloblastomaMr. Dorostkar isExperienced. Learn about Medulloblastoma.
- MelanomaMr. Dorostkar isExperienced. Learn about Melanoma.
- Movement DisordersMr. Dorostkar isExperienced. Learn about Movement Disorders.
- Neurofibromatosis Type 2 (NF2)Mr. Dorostkar isExperienced. Learn about Neurofibromatosis Type 2 (NF2).
- NeurosarcoidosisMr. Dorostkar isExperienced. Learn about Neurosarcoidosis.
- OligodendrogliomaMr. Dorostkar isExperienced. Learn about Oligodendroglioma.
- Parkinson's DiseaseMr. Dorostkar isExperienced. Learn about Parkinson's Disease.
- Pitt-Hopkins SyndromeMr. Dorostkar isExperienced. Learn about Pitt-Hopkins Syndrome.
- Rhabdoid TumorMr. Dorostkar isExperienced. Learn about Rhabdoid Tumor.
- Spinal TumorMr. Dorostkar isExperienced. Learn about Spinal Tumor.